1. Home
  2. APLT vs LOOP Comparison

APLT vs LOOP Comparison

Compare APLT & LOOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • LOOP
  • Stock Information
  • Founded
  • APLT 2016
  • LOOP 2010
  • Country
  • APLT United States
  • LOOP Canada
  • Employees
  • APLT N/A
  • LOOP N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • LOOP Major Chemicals
  • Sector
  • APLT Health Care
  • LOOP Industrials
  • Exchange
  • APLT Nasdaq
  • LOOP Nasdaq
  • Market Cap
  • APLT 63.6M
  • LOOP 72.5M
  • IPO Year
  • APLT 2019
  • LOOP N/A
  • Fundamental
  • Price
  • APLT $0.41
  • LOOP $1.77
  • Analyst Decision
  • APLT Buy
  • LOOP
  • Analyst Count
  • APLT 6
  • LOOP 0
  • Target Price
  • APLT $6.10
  • LOOP N/A
  • AVG Volume (30 Days)
  • APLT 771.9K
  • LOOP 137.6K
  • Earning Date
  • APLT 11-06-2025
  • LOOP 10-14-2025
  • Dividend Yield
  • APLT N/A
  • LOOP N/A
  • EPS Growth
  • APLT N/A
  • LOOP N/A
  • EPS
  • APLT N/A
  • LOOP N/A
  • Revenue
  • APLT $121,000.00
  • LOOP $11,135,000.00
  • Revenue This Year
  • APLT N/A
  • LOOP N/A
  • Revenue Next Year
  • APLT $5,931.24
  • LOOP $777.41
  • P/E Ratio
  • APLT N/A
  • LOOP N/A
  • Revenue Growth
  • APLT N/A
  • LOOP 8335.61
  • 52 Week Low
  • APLT $0.30
  • LOOP $0.85
  • 52 Week High
  • APLT $10.62
  • LOOP $2.29
  • Technical
  • Relative Strength Index (RSI)
  • APLT 38.50
  • LOOP 54.13
  • Support Level
  • APLT $0.40
  • LOOP $1.65
  • Resistance Level
  • APLT $0.46
  • LOOP $2.01
  • Average True Range (ATR)
  • APLT 0.03
  • LOOP 0.17
  • MACD
  • APLT -0.01
  • LOOP 0.01
  • Stochastic Oscillator
  • APLT 7.74
  • LOOP 47.69

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

Share on Social Networks: